San Antonio researcher receives top American diabetes award
June 12, 2008
Studies of insulin resistance, development of frontline therapies shape his legacy.
Category
June 12, 2008
Studies of insulin resistance, development of frontline therapies shape his legacy.
June 12, 2008
In a research study of hundreds of patients facing the prospect of developing type 2 diabetes, the oral drug pioglitazone (brand name: Actos®) reduced the rate of conversion to the disease by 81 percent in the active therapy group compared to those taking a placebo, the study leader, Ralph A. DeFronzo, M.D., reported June 9 during the 68th Scientific Sessions of the American Diabetes Association in San Francisco.
June 11, 2008
UT Health Science Center, CHRISTUS Santa Rosa Health Care have removedmore kidney, bladder tumors with the technology than any academic center in Texas.
June 6, 2008
A new national Web resource designed to promote innovation in the delivery of health care was launched this spring by the Agency for Healthcare Research and Quality (AHRQ).
June 5, 2008
Doctors no longer make house calls, so many environmental factors that would clue in physicians as to why their patients are sick aren’t considered, much less discussed.
June 4, 2008
According to the National Highway Traffic Safety Administration, motor vehicle crashes remain the leading cause of death among persons ages 4 to 33.